{"id":13062,"date":"2009-03-10T09:50:13","date_gmt":"2009-03-10T09:50:13","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=13062"},"modified":"2009-03-10T09:50:13","modified_gmt":"2009-03-10T09:50:13","slug":"ad-pharma-am-renuntat-la-ideea-listarii-la-bvb-2","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=13062","title":{"rendered":"A&amp;D Pharma: Am renuntat la ideea listarii la BVB"},"content":{"rendered":"<p>&ldquo;A fost o idee prin luna iulie-august a anului trecut, atunci cand am venit in companie, sa o listam la BVB, dar conditiile s-au schimbat foarte mult de atunci si am renuntat la aceasta idee cel putin pentru anul acesta&rdquo;, a declarat Dimitris Sophocleous, directorul financial al A&amp;D Pharma.<\/p>\n<p>Robert Popescu, CEO-ul interimar al companiei, a explicat ca posibilitatea listarii secundare (actiunile A&amp;D Pharma se tranzactioneaza sub forma de GDR-uri pe piata reglementata a Bursei de Valori din Londra incepand cu octombrie 2006 &ndash; n. red.) ar fi dus la o crestere a nivelului lichiditatilor, dar ca actualele conditii nu mai permit aceasta miscare.<\/p>\n<p>CEO-ul A&amp;D Pharma a mai precizat ca la sfarsitul lunii mai va fi refinantata linia de credit de 100 de milioane de euro contractata de la un grup de banci condus de Citibank; din total, compania a utilizat 75% pana in prezent. Banii obtinuti vor fi folositi pentru finantarea activitatii curente.<\/p>\n<p>Cititi <a href=\"http:\/\/www.businessmagazin.ro\/actualitate\/afaceri\/reorganizarea-a-costat-a-d-pharma-6-2-mil-euro-in-2008.html?5846;4036435\">aici<\/a> mai multe detalii despre <a href=\"http:\/\/www.businessmagazin.ro\/actualitate\/afaceri\/reorganizarea-a-costat-a-d-pharma-6-2-mil-euro-in-2008.html?5846;4036435\">rezultatele financiare ale A&amp;D Pharma pe 2008 <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Grupul farmaceutic A&amp;D Pharma, liderul pietei de distributie si retail la nivel local, a anuntat ca a renuntat la ideea listarii la Bursa de Valori Bucuresti (BVB).<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[511],"tags":[8813,148,7592,7364,8815],"class_list":["post-13062","post","type-post","status-publish","format-standard","hentry","category-afaceri","tag-ad-pharma","tag-bvb","tag-farmaceutice","tag-listare","tag-sensiblu"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/13062","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13062"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/13062\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13062"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=13062"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=13062"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}